Please provide your email address to receive an email when new articles are posted on . In a new study, the use of CPAP and high-flow nasal oxygen to treat patients with moderate to severe COVID-19 ...

The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought, suggest ...

July 26 (UPI) --Cardiovascular risks linked to sleep apnea are caused by a reduction in blood oxygen levels, according to National Institutes of Health-supported study published in the American ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with COVID-19-related acute respiratory ...

Share on Pinterest Lower blood oxygen levels due to sleep apnea may explain the higher cardiovascular risk faced by people with this condition. Image credit: milorad kravic/Getty Images. A new study ...

The new treatment could hit the market as early as 2027.

May 8 (UPI) --Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says. The drop in blood oxygen levels that occurs during a sleep ...